KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Other Operating Expenses (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Other Operating Expenses for 16 consecutive years, with -$27.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 33.54% to -$27.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.6 million, a 278.31% increase, with the full-year FY2025 number at $25.6 million, up 178.78% from a year prior.
  • Other Operating Expenses was -$27.1 million for Q4 2025 at Biolife Solutions, down from $13.4 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $102.0 million in Q2 2022 to a low of -$148.3 million in Q4 2022.
  • A 5-year average of $2.7 million and a median of $9.3 million in 2024 define the central range for Other Operating Expenses.
  • Biggest YoY gain for Other Operating Expenses was 2545.72% in 2022; the steepest drop was 1772.81% in 2022.
  • Biolife Solutions' Other Operating Expenses stood at -$7.9 million in 2021, then plummeted by 1772.81% to -$148.3 million in 2022, then soared by 54.13% to -$68.0 million in 2023, then soared by 70.13% to -$20.3 million in 2024, then plummeted by 33.54% to -$27.1 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Other Operating Expenses are -$27.1 million (Q4 2025), $13.4 million (Q3 2025), and $27.9 million (Q2 2025).